✦ LIBER ✦

Intensive recombinant interleukin-2 and alpha-interferon therapy in patients with advanced head and neck squamous carcinoma

✍ Scribed by Susan G. Urba; Arlene A. Forastiere; Gregory T. Wolf; Philip C. Amrein

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 560 KB
Volume: 71
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19930401)71:7<2326::aid-cncr2820710725>3.0.co;2-h

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hyperfractionated accelerated radiation

Hyperfractionated accelerated radiation therapy with concurrent interferon alpha and isotretinoin for patients with locally advanced squamous cell carcinoma of the head and neck

✍ J. Vrouvas; G. Kolitsi; C. Kyprianou; Ph. Angelakis 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Phase II study of N-phosphonacetyl-L-asp

Phase II study of N-phosphonacetyl-L-aspartate, recombinant interferon-alpha, and fluorouracil infusion in advanced squamous cell carcinoma of the head and neck

✍ Corey J. Langer; David Schaebler; Edward Sauter; Deborah DeMaria; Cheryl Johnson 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Background: 5-fluorouracil (5-fu), as a single agent, produces a 15% response rate in advanced squamous cell carcinoma of the head and neck (scchn). n-phosphonacetyl-l-aspartate (pala) inhibits pyrimidine biosynthesis and increases incorporation of 5-fu metabolites into ribonucleic acid (rna). r

In vitro immune modulation by thymosin a

In vitro immune modulation by thymosin alpha1 in patients with head and neck squamous cell carcinoma

✍ Wolf, Gregory T. ;Peterson, Karen A. ;Lovett, Edmund J. 📂 Article 📅 1985 🏛 Wiley (John Wiley & Sons) ⚖ 678 KB

To determine if patients with head and neck squamous cell carcinoma represent an appropriate population for immune reconstitution with thymosin alpha,. leukocyte migration inhibition (LMI) in response to phytohemagglutinin was measured in 24 previously untreated patients with head and neck cancer, a

Cytotoxic In vitro function in patients

Cytotoxic In vitro function in patients with metastatic renal cell carcinoma before and after alpha-2b-interferon therapy effects of activation with recombinant interleukin-2

✍ Cristina Feruglio; Renato Zambello; Livio Trentin; Pietro Bulian; Tiziano France 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 658 KB

Pharmacodynamic evaluation of temsirolim

Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced-stage head and neck squamous cell carcinoma

✍ Oleksandr Ekshyyan; Glenn M. Mills; Timothy Lian; Nazanin Amirghahari; Xiaohua R 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 1 views

## Abstract ## Background: Activation of the mammalian target of rapamycin (mTOR) pathway in surgical margins of head and neck squamous cell carcinoma (HNSCC) is a predictor of recurrence and patients with minimal residual disease may benefit from adjuvant therapy with temsirolimus, an mTOR inhibi

Chemotherapy prior to local therapy in a

Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck. Preliminary assessment of an intensive drug regimen

✍ E. George Elias; Paul B. Chretien; Edgar Monnard; Tariq Khan; William H. Bouchel 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 589 KB

33 patients with locally and regionally advanced squamous cell carcinoma of the head and neck were treated with a single course of a combination of chemotherapy. Twenty-two of these patients were previously untreated, while the other eleven were previously treated with radiation therapy and/or surge